Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)

Clinical trial NCT04973280 · COMPLETED

Trial details

NCT number: NCT04973280
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndromes Beta-thalassemia

Start date: 2021-07-26
Primary completion: 2022-07-21
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.